The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discriminating subtypes in advanced breast cancer with ctDNA methylation profiling.
 
Nida Pasha
No Relationships to Disclose
 
Ros Cutts
No Relationships to Disclose
 
Aya Amenssag
No Relationships to Disclose
 
Sarah Hrebien
No Relationships to Disclose
 
Aditi Gulati
No Relationships to Disclose
 
Qiong Gao
No Relationships to Disclose
 
Syed Haider
No Relationships to Disclose
 
Rebecca Roylance
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Lilly; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - BMS; Pfizer; Roche/Genentech
 
Andrew N. J. Tutt
Employment - Institute of Cancer Research
Leadership - Institute of Cancer Research
Stock and Other Ownership Interests - InBiomotion
Honoraria - PAGE Therapeutics (Inst)
Consulting or Advisory Role - American College of Independent Medical Examiners (Inst); AstraZeneca; AstraZeneca; AstraZeneca (Inst); Cancer Panels; EM Partners; GE Healthcare (Inst); Gilead Sciences; Gilead Sciences (Inst); Guardant Health (Inst); MD Anderson Cancer Center; Merck Serono (Inst); Research to Practice; Tango Therapeutics (Inst); VJOncology (Inst)
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck KGaA (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - I have i the past and may in the future be in Receipt of payments under my employer (ICR London) Rewards to inventors Scheme associated with patents held by ICR associated with the use of PARP inhibitors in BRCA 1/2 deficient cancers
Expert Testimony - National Institute for Health and Clinical Excellence (Inst); National Institute for Health and Clinical Excellence (Inst); National Institute for Health and Clinical Excellence (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Breast Cancer Now Charity (Inst); Cancer Research UK (Inst); GBCC; GBCC; Innovation In Breast Cancer Symposium (Inst)
(OPTIONAL) Uncompensated Relationships - ESMO Breast Cancer Guidelines (Inst); St Gallen Early Breast Cancer Consensus Conference
 
Richard D. Baird
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo (Inst); Molecular Partners (Inst); Novartis (Inst); Roche/Genentech (Inst); Shionogi (Inst)
Research Funding - AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Carrick Therapeutics (Inst); G1 Therapeutics (Inst); Genentech (Inst); Molecular Partners (Inst); Roche (Inst); Sanofi (Inst); Shionogi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Molecular Partners; Shionogi
 
Iain R. MacPherson
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Owkin; Pfizer; Roche; Stemline Therapeutics
Speakers' Bureau - Daiichi Sankyo UK Ltd
Research Funding - Allarity Therapeutics (Inst); AstraZeneca (Inst); Byondis (Inst); Celldex (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Novartis Pharmaceuticals UK Ltd.
 
Alistair E. Ring
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche UK; Seagen
Research Funding - AstraZeneca (Inst)
 
Stephen R. D. Johnston
Honoraria - AstraZeneca; Lilly; Pfizer
Consulting or Advisory Role - Genzyme; Lilly; Pfizer; Puma Biotechnology
Research Funding - Pfizer (Inst)
Expert Testimony - Novartis
 
Alicia Frances Clare Okines
Stock and Other Ownership Interests - AstraZeneca (I)
Honoraria - AstraZeneca; Gilead Sciences; Seagen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Pfizer; Roche/Genentech; Seagen
Speakers' Bureau - AstraZeneca; Eisai; Gilead Sciences; Lilly; Pfizer; Seagen
Research Funding - Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; LEO Pharma; Lilly; Roche
 
Isaac Garcia-Murillas
Consulting or Advisory Role - Bio-Rad; Luminex
Research Funding - Bio-Rad (Inst); Guardant Health (Inst); Invitae (Inst); Natera (Inst); NeoGenomics Laboratories (Inst); Personalis (Inst)
Travel, Accommodations, Expenses - Bio-Rad; InVitae; Natera; NeoGenomics Laboratories
 
Sarah Filippi
No Relationships to Disclose
 
Nicholas C. Turner
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Guardant Health; Inivata; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Relay Therapeutics; Repare Therapeutics; Roche
Research Funding - AstraZeneca (Inst); Guardant Health (Inst); Inivata (Inst); InVitae (Inst); Merck Sharpe and Dohme (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst); Roche (Inst)